{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T18:18:35Z","timestamp":1770747515365,"version":"3.49.0"},"reference-count":39,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T00:00:00Z","timestamp":1456099200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0150030","type":"journal-article","created":{"date-parts":[[2016,2,22]],"date-time":"2016-02-22T18:51:12Z","timestamp":1456167072000},"page":"e0150030","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":30,"title":["Evaluation of Costimulatory Molecules in Peripheral Blood Lymphocytes of Canine Patients with Histiocytic Sarcoma"],"prefix":"10.1371","volume":"11","author":[{"given":"Michihito","family":"Tagawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Konnai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,2,22]]},"reference":[{"key":"ref1","first-page":"1041","article-title":"Canine histyocytic neoplasia: an overview","volume":"48","author":"AR Fulmer","year":"2007","journal-title":"Can Vet J"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1354\/vp.43-5-632","article-title":"Canine hemophagocytic histiocytic sarcoma: A proliferative disorder of CD11d+ macrophages","volume":"43","author":"PF Moore","year":"2006","journal-title":"Vet Pathol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1292\/jvms.13-0414","article-title":"Clinical characteristics and prognostic factors in dogs with histiocytic sarcomas in Japan","volume":"76","author":"M Takahashi","year":"2014","journal-title":"J Vet Med Sci"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1354\/vp.39-1-66","article-title":"The diagnosis and prognosis of synovial tumors in dogs: 35 cases","volume":"39","author":"LE Craig","year":"2002","journal-title":"Vet Pathol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1939-1676.2007.tb02937.x","article-title":"CCNU for the treatment of dogs with histiocytic sarcoma","volume":"21","author":"KA Skorupski","year":"2007","journal-title":"J Vet Intern Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1939-1676.2010.0588.x","article-title":"Phase II, open-label trial of single-agent CCNU in dogs with previously untreated histiocytic sarcoma","volume":"24","author":"KM Rassnick","year":"2010","journal-title":"J Vet Intern Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1146\/annurev.immunol.23.021704.115611","article-title":"The B7 family revisited","volume":"23","author":"RJ Greenwald","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1038\/ni.2870","article-title":"New inhibitory signaling by CTLA-4","volume":"15","author":"C W\u00fclfing","year":"2014","journal-title":"Nat Immunol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri1349","article-title":"Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity","volume":"4","author":"L Chen","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.vetimm.2009.10.006","article-title":"Structure and function of programmed death (PD) molecules","volume":"15","author":"A Folkl","year":"2010","journal-title":"Vet Immunol Immunopathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/0300985813510413","article-title":"A review of histiocytic diseases of dogs and cats","volume":"51","author":"PF Moore","year":"2014","journal-title":"Vet Pathol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/jvim.12244","article-title":"Comparative analysis of mRNA expression of surface antigens between histiocytic and nonhistiocytic sarcoma in dogs","volume":"28","author":"H Yamazaki","year":"2014","journal-title":"J Vet Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.tvjl.2013.07.030","article-title":"Monocyte chemotactic protein-1 and other inflammatory parameters in Bernese Mountain dogs with disseminated histiocytic sarcoma","volume":"198","author":"LN Nielsen","year":"2013","journal-title":"Vet J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1476-5829.2011.00285.x","article-title":"Investigation of a screening programme and the possible identification of biomarkers for early disseminated histiocytic sarcoma in Bernese Mountain dogs","volume":"10","author":"LN Nielsen","year":"2012","journal-title":"Vet Comp Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1939-1676.2010.0543.x","article-title":"Evaluation of serum ferritin as a tumor marker for canine histiocytic sarcoma","volume":"24","author":"KR Friedrichs","year":"2010","journal-title":"J Vet Intern Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1399-3038.2005.00274.x","article-title":"CTLA-4 expression in T cells of patients with atopic dermatitis","volume":"16","author":"SY Choi","year":"2005","journal-title":"Pediatr Allergy Immunol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.2004.02502.x","article-title":"Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection","volume":"137","author":"H Ayukawa","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/clim.2001.5003","article-title":"Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis","volume":"99","author":"LI Salazar-Fontana","year":"2001","journal-title":"Clin Immunol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.2307\/3576075","article-title":"Separation of human lymphocytes on Ficoll-Paque gradients: stimulation of cells and depletion of a concanavalin-A responsive radioresistant subpopulation","volume":"95","author":"R Kol","year":"1983","journal-title":"Radiat Res"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1292\/jvms.68.1219","article-title":"Phenotypic analysis of hepatic T lymphocytes in a dog with chronic hepatitis","volume":"68","author":"M Sakai","year":"2006","journal-title":"J Vet Med Sci"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/TP.0b013e31820f07ff","article-title":"Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation","volume":"91","author":"SS Graves","year":"2011","journal-title":"Transplantation"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"5542","DOI":"10.4049\/jimmunol.1301810","article-title":"Programmed death 1-mediated T cell exhaustion during visceral leishmaniasis impairs phagocyte function","volume":"191","author":"KJ Esch","year":"2013","journal-title":"J Immunol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1111\/ajt.12834","article-title":"Understanding the CD28\/CTLA-4 (CD152) pathway and its implications for costimulatory blockade","volume":"14","author":"D Gardner","year":"2014","journal-title":"Am J Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"926321","DOI":"10.1155\/2012\/926321","article-title":"Targeting costimulatory molecules to improve antitumor immunity","volume":"2012","author":"D Capece","year":"2012","journal-title":"J Biomed Biotechnol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1056\/NEJMoa1302369","article-title":"Nivolumab plus ipilimumab in advanced melanoma","volume":"369","author":"JD Wolchok","year":"2013","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"5300","DOI":"10.1158\/1078-0432.CCR-13-0143","article-title":"CTLA-4 and PD-1\/PD-L1 blockade: new immunotherapeutic modalities with durable clinical benefit in melanoma patients","volume":"19","author":"PA Ott","year":"2013","journal-title":"Clin Cancer Res"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1006\/clim.2001.5003","article-title":"Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis","volume":"99","author":"LI Salazar-Fontana","year":"2001","journal-title":"Clin Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.exger.2003.09.026","article-title":"Proliferation and apoptosis of human CD8(+)CD28(+) and CD8(+)CD28(-) lymphocytes during aging","volume":"39","author":"A Brzezi\u0144ska","year":"2004","journal-title":"Exp Gerontol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.0105-2896.2006.00419.x","article-title":"The role of CD28 and cytotoxic T-lymphocyte antigen-4 (CTLA-4) in regulatory T-cell biology","volume":"212","author":"DM Sansom","year":"2006","journal-title":"Immunol Rev"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1126\/science.271.5256.1734","article-title":"Enhancement of antitumor immunity by CTLA-4 blockade","volume":"271","author":"DR Leach","year":"1996","journal-title":"Science"},{"key":"ref31","first-page":"245","article-title":"Anti-cytotoxic T lymphocyte antigen-4 antibodies in melanoma","volume":"17","author":"G Tosti","year":"2013","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"FS Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/jso.23281","article-title":"Increased PD-1 expression on CD4+ and CD8+ T cells is involved in immune evasion in gastric cancer","volume":"107","author":"H Saito","year":"2013","journal-title":"J Surg Oncol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1189\/jlb.1212631","article-title":"At the bedside: CTLA-4- and PD-1-blocking antibodies in cancer immunotherapy","volume":"94","author":"MK Callahan","year":"2013","journal-title":"J Leukoc Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","article-title":"PD-1 and its ligands in tolerance and immunity","volume":"26","author":"ME Keir","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3892\/ol.2014.2391","article-title":"Clinical significance of serum T helper 1\/T helper 2 cytokine shift in patients with non-small cell lung cancer","volume":"8","author":"J Li","year":"2014","journal-title":"Oncol Lett"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.lungcan.2012.04.011","article-title":"Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC)","volume":"77","author":"N Erfani","year":"2012","journal-title":"Lung Cancer"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.leu.2403907","article-title":"Increased expression of CD152 (CTLA-4) by normal T lymphocytes in untreated patients with B-cell chronic lymphocytic leukemia","volume":"19","author":"M Motta","year":"2005","journal-title":"Leukemia"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s12253-010-9256-8","article-title":"Increased CTLA-4 and FOXP3 transcripts in peripheral blood mononuclear cells of patients with breast cancer","volume":"16","author":"M Jaberipour","year":"2010","journal-title":"Pathol Oncol Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0150030","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T21:41:14Z","timestamp":1567633274000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0150030"}},"subtitle":[],"editor":[{"given":"Jagadeesh","family":"Bayry","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,2,22]]},"references-count":39,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0150030","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,22]]}}}